Fact CheckerSign in

NCT06473428Not yet recruiting

Investigating Muscle Training's Respiratory Outcomes and Voice Enhancement in Parkinson's Disease

The Association of Pulmonary Function, Diaphragm Thickness and Excursion, and Phonatory Measures in Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 25 Jun 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study aims to investigate the effects of different types of respiratory muscle training on lung function, diaphragm movement, and voice quality in patients with Parkinson's disease (PD). PD often leads to breathing difficulties and voice abnormalities due to weakened respiratory muscles and reduced diaphragm mobility. The study will involve 45 participants with PD, randomly assigned to three groups: one group will perform inspiratory muscle training, the second group will perform both inspiratory and expiratory muscle training, and the third group will receive placebo-controlled expiratory muscle training. The hypothesis is that targeted respiratory muscle training will significantly improve pulmonary function, diaphragm excursion, and phonatory measures compared to the placebo group. The findings aim to develop effective rehabilitation strategies to enhance the quality of life and communication abilities in individuals with PD.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
45 (estimated)
First submitted
27 May 2024
Start date
1 Jul 2024
Primary completion date
30 Jun 2026
Lead sponsor
National Taiwan University Hospital
NCT number
NCT06473428

What you commit to

  • Study type: Interventional
  • Planned participants: 45
  • From 1 Jul 2024 to the primary completion date, 30 Jun 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with recent chest/abdominal surgery

Other illness

  • Patients with cognitive impairment
  • Patients with respiratory or other neurological diseases

Other

  • Patients with smoking history
  • Patients with respiratory complications
  • Patients with clinical instability
  • Patients who are unable to perform pulmonary function tests correctly

Who the study is looking for

  • Patients with Parkinson's disease (Hoehn \& Yahr stage I-III),
  • Patients aged 30-85
  • Patients with stable medical condition, regular medication adherence, and ability to follow instructions.

Age in the registry: 30 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.